Find investors
← Back to all investors
John Riney
ResearchedAngel Investors

John Riney

Senior Associate

Angel InvestorsSeed Round
Pitch John

Get their honest, personalized take on your startup.

Sign in to pitch John →

At a glance

Full Name
John Riney
Title
Vice President, Private Investments (listed as such on Castellan Group's firm site; aggregators such as RocketReach and his prior LinkedIn headline describe the role as "Senior Associate" / "Direct Investments")
Firm
Castellan Group, LLC
Firm Type
SEC-registered investment advisor (RIA) with a private-equity / venture-capital and family-office practice; wholly owned by a perpetual charitable trust
Investment Stage
Early-stage venture capital (seed through Series A)
Sector Focus
Healthcare technology / health tech (also business products & services within the firm's fund mandate)
Geographic Focus
United States
Location
Louisville, Kentucky (firm HQ; secondary office in Jupiter, Florida)

Background

John Riney is a member of the Private Investments team at Castellan Group, a Louisville, Kentucky–based registered investment advisor that combines wealth management, private equity, venture capital, and family-office services and is unusually structured as an independent RIA wholly owned by a perpetual charitable trust (with most profits donated to charity). At Castellan he focuses on sourcing and evaluating investment opportunities, managing due diligence, and supporting portfolio companies, with a concentration on venture-capital investments in healthcare technology.

Riney began his career in investment banking before moving into private equity and private credit investing at Falcon Investment Advisors (the Boston mezzanine/private-credit manager later owned by Onex and known as Onex Falcon). His background also includes experience associated with Farmer's Business Network, an agtech company. This private-credit and direct-investment grounding informs his current work sourcing and structuring private deals.

He holds a Bachelor of Science in Business Administration from Washington University in St. Louis (2012–2015), with a concentration in Finance and in Economics & Strategy.

Investment Thesis & Focus

  • Invests through Castellan Group's private-investments practice, targeting early-stage venture capital opportunities — the firm's disclosed deals have been at the Series A stage.
  • Sector focus on healthcare technology: the private team is described as concentrating on "deal sourcing, due diligence, and closing venture capital investments in healthcare technology."
  • Castellan manages Aging Innovation Fund I, an early-stage venture fund based in Louisville that invests in the U.S. and targets healthcare, health tech, and business products & services — a signal of the firm's thematic interests around aging and healthcare innovation.
  • Deals are often executed through dedicated, closed-end SPVs (as with the Medxoom Series A), reflecting a deal-by-deal, hands-on approach that includes advising management and providing oversight.
  • Fit profile: founders in healthcare/health-tech building at the seed-to-Series-A stage, where a smaller RIA-backed investor can lead or co-lead a focused round and stay actively involved post-investment.

Notable Investments

  • Segmed — Castellan's most recent disclosed investment, participating in Segmed's Series A (September 3, 2024). Segmed operates in medical-imaging/health data.
  • Medxoom — Healthcare-financing and member-benefits platform simplifying pricing for medical procedures; Castellan led a Series A financing through a closed-end SPV and advised management, recording a portfolio exit on July 19, 2023.

Unlock the full research

Get how to approach them, recent activity, sources, contact links — plus pitch their AI twin for a candid read on your raise.

One-time. Stays unlocked for you.